Roche builds strength in molecular diagnostics

Share this article:

Roche has scooped up DNA sequencing firm Genia Technologies, reports the Wall Street Journal. The deal includes $125 million in an upfront payment, and the WSJ notes Monday's deal synchs with its acquisition of the molecular diagnostics firm IQuum and Roche's efforts to bolster its standing in this diagnostics space.

Roche attempted a hostile takeover of San Diego-based DNA sequencing firm Illumina in 2012. Illumina CEO Jay Flatley rallied stockholders to reject the takeover.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.